StockData
Cognition Therapeutics Inc logo

Cognition Therapeutics Inc (CGTX) stock

CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.63−0.01 (-1.39%)

Close on Nov 17, 2026Market cap $59.90MP/E –Yield –

Cognition Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Cognition Therapeutics's total assets was $38.90M at Jun 30, 2026. For fiscal 2025 it was $48.39M, up 60.1% from the year before. The highest annual figure on record is $59.14M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$48.39M+60.1%
FY2024Dec 31, 2024$30.23M-14.0%
FY2023Dec 31, 2023$35.16M-30.3%
FY2022Dec 31, 2022$50.43M-14.7%
FY2021Dec 31, 2021$59.14M+730.7%
FY2020Dec 31, 2020$7.12M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$38.90M+98.2%
Q1 FY2026Mar 31, 2026$36.14M+53.8%
Q4 FY2025Dec 31, 2025$48.39M+60.1%
Q3 FY2025Sep 30, 2025$43.40M+57.3%
Q2 FY2025Jun 30, 2025$19.62M-42.9%
Q1 FY2025Mar 31, 2025$23.50M-39.5%
Q4 FY2024Dec 31, 2024$30.23M-14.0%
Q3 FY2024Sep 30, 2024$27.58M-28.9%
Q2 FY2024Jun 30, 2024$34.37M-21.8%
Q1 FY2024Mar 31, 2024$38.85M-14.9%
Q4 FY2023Dec 31, 2023$35.16M-30.3%
Q3 FY2023Sep 30, 2023$38.77M-27.6%
Q2 FY2023Jun 30, 2023$43.96M-16.8%
Q1 FY2023Mar 31, 2023$45.66M-22.2%
Q4 FY2022Dec 31, 2022$50.43M-14.7%
Q3 FY2022Sep 30, 2022$53.56M+300.0%
Q2 FY2022Jun 30, 2022$52.81M+641.8%
Q1 FY2022Mar 31, 2022$58.70M–
Q4 FY2021Dec 31, 2021$59.14M–
Q3 FY2021Sep 30, 2021$13.39M–
Q4 FY2020Dec 31, 2020$7.12M–

More Cognition Therapeutics figures

See a number that looks wrong?